• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碘番酸对人补体C3和B因子的体外作用。

Effects of iodipamide on human C3 and factor B in vitro.

作者信息

Durda P J, Pagano R J, Bauman N, Brockman J A

出版信息

J Allergy Clin Immunol. 1982 Nov;70(5):353-60. doi: 10.1016/0091-6749(82)90024-0.

DOI:10.1016/0091-6749(82)90024-0
PMID:6922882
Abstract

The effects of iodipamide on C3 and factor B in normal human serum and in purified form have been examined by immunoelectrophoresis and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Temperature-dependent changes in immunoelectrophoretic profiles have been observed; however, these are not the same as those obtained after treatment of normal human serum (NHS) with cobra venom factor Naja naja. Analyses of iodipamide-treated NHS and purified C3 and factor B by reducing SDS-PAGE indicate that no macromolecular changes have occurred in C3 and factor B that can be ascribed to proteolysis (i.e., activation). The changes observed in C3 and factor B, including loss of hemolytic activity, appear to be due to direct interactions between iodipamide and C3 and factor B. In the case of factor B, iodipamide treatment at 37 degrees C induces aggregation, which is reversible upon reduction with beta-mercaptoethanol.

摘要

已通过免疫电泳和十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE)研究了碘番酸对正常人血清及纯化形式的C3和B因子的影响。观察到免疫电泳图谱随温度变化;然而,这些变化与用眼镜蛇毒因子(眼镜蛇)处理正常人血清(NHS)后获得的变化不同。通过还原SDS-PAGE对经碘番酸处理的NHS以及纯化的C3和B因子进行分析表明,C3和B因子未发生可归因于蛋白水解(即激活)的大分子变化。在C3和B因子中观察到的变化,包括溶血活性丧失,似乎是由于碘番酸与C3和B因子之间的直接相互作用所致。就B因子而言,在37℃下用碘番酸处理会诱导聚集,用β-巯基乙醇还原后这种聚集是可逆的。

相似文献

1
Effects of iodipamide on human C3 and factor B in vitro.碘番酸对人补体C3和B因子的体外作用。
J Allergy Clin Immunol. 1982 Nov;70(5):353-60. doi: 10.1016/0091-6749(82)90024-0.
2
Effect of metrizamide, a nonionic radiographic contrast agent, on human serum complement. Comparison with ionic contrast media.
Int Arch Allergy Appl Immunol. 1984;73(4):321-9. doi: 10.1159/000233492.
3
A novel cleavage product of human complement component C3 with structural and functional properties of cobra venom factor.一种具有眼镜蛇毒因子结构和功能特性的人补体成分C3新型裂解产物。
J Biol Chem. 1988 Sep 5;263(25):12690-7.
4
Comparison of Naja n. naja and Naja h. haje cobra-venom factors: correlation between binding affinity for the fifth component of complement and mediation of its cleavage.眼镜蛇指名亚种和埃及眼镜蛇蛇毒因子的比较:与补体第五成分的结合亲和力及其裂解介导作用之间的相关性。
Immunobiology. 1980 Dec;157(4-5):499-514. doi: 10.1016/s0171-2985(80)80018-0.
5
Isolation and properties of a complement inhibitor from Naja haje venom, distinct from known anticomplementary factors in cobra venom.
Scand J Immunol. 1981 Aug;14(2):109-20. doi: 10.1111/j.1365-3083.1981.tb00190.x.
6
Endogenous inhibitors of factor B.补体因子B的内源性抑制剂
Microbiol Immunol. 1983;27(12):1079-91. doi: 10.1111/j.1348-0421.1983.tb02941.x.
7
Inhibition of the classical and alternative pathways of human and guinea pig complement by pyran copolymer.吡喃共聚物对人和豚鼠补体经典途径及替代途径的抑制作用
Int Arch Allergy Appl Immunol. 1981;66(3):304-9. doi: 10.1159/000232834.
8
In vitro effects of radiographic contrast media on the complement system.放射造影剂对补体系统的体外作用。
J Allergy Clin Immunol. 1980 Sep;66(3):217-22. doi: 10.1016/0091-6749(80)90042-1.
9
Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement.补体替代途径C3转化酶成分备解素与B因子之间相互作用的分析。
Biochem J. 1988 Aug 1;253(3):667-75. doi: 10.1042/bj2530667.
10
Formation of C3-IgG complexes in serum by aggregated IgG and by non-immunoglobulin activators of complement.血清中通过聚集的IgG和补体的非免疫球蛋白激活剂形成C3-IgG复合物。
Immunology. 1987 Jun;61(2):105-10.

引用本文的文献

1
Anaphylactoid reactions to radiocontrast material.对放射性造影剂的类过敏反应。
Clin Rev Allergy. 1991 Fall-Winter;9(3-4):319-38. doi: 10.1007/BF02802311.